MedTrace Logo

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

NCT03000049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-12-22

No results posted yet for this study

Summary

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.

Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.

Conditions

  • Sepsis Septic Shock

Interventions

OTHER

bedside blood culture

Sponsors & Collaborators

  • University Medicine Greifswald

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-07-31
Completion
2017-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000049 on ClinicalTrials.gov